查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2065199

智慧藥丸市場預測至2034年—按產品類型、技術、目標部位、分銷管道、應用、最終用戶和地區分類的全球分析

Smart Pills Market Forecasts to 2034 - Global Analysis By Product Type (Capsule Endoscopy, Drug Delivery Smart Pills, and Patient Monitoring Smart Pills), Technology, Target Area, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球智慧藥丸市場預計將在 2026 年達到 42 億美元，到 2034 年達到 98 億美元，在預測期內以 11.2% 的複合年成長率成長。

智慧藥丸（也稱為可吞服電子膠囊）是一種先進的醫療設備，它整合了微型感測器、攝影機和無線發送器，可在通過消化道時即時擷取生理和解剖數據。這些設備能夠實現對胃腸道疾病的非侵入性診斷、藥物的精準輸送以及對患者的持續監測。透過將資料傳輸到外部接收器或雲端平台，智慧藥丸能夠幫助臨床醫生做出及時準確的決策，從而提高診斷準確率，並減少傳統侵入性內視鏡檢查和住院次數。

胃腸道疾病發生率不斷上升，以及對非侵入性診斷方法的需求日益成長

在全球範圍內，克隆氏症、大腸直腸癌和大腸激躁症等胃腸道疾病的快速成長推動了對非侵入性診斷工具的需求。智慧膠囊為傳統內視鏡檢查提供了一種更便捷的替代方案，無需鎮靜或承受手術帶來的不適，即可提供整個胃腸道的高解析度影像。隨著醫療系統優先考慮早期檢測和以患者為中心的護理模式，膠囊內視鏡的應用正在加速普及。此外，醫生們日益認知到智慧膠囊在檢測不明原因的消化道出血和小腸病變方面的診斷優勢，這也進一步促進了市場成長。

智慧藥丸設備高成本且保險覆蓋範圍有限

儘管智慧膠囊具有臨床益處，但對於全球相當一部分患者而言，其高昂的價格仍然是一大障礙。該設備的高昂成本源自於其複雜的製造程序，涉及精密的微型組件。在許多醫療市場，尤其是在開發中國家，膠囊內視鏡的保險報銷體係不完善或不健全，給病人帶來了沉重的經濟負擔。此外，資料管理系統和影像分析設備的相關成本也進一步限制了小規模醫療機構對該技術的接受度。這些經濟障礙持續限制智慧膠囊在非高所得群體和擁有完善醫療保險的病患小組中的市場滲透。

整合人工智慧分析和遠端監控功能。

人工智慧與智慧膠囊技術的融合，正在為病灶自動檢測、異常即時標記和預測性診斷帶來變革性機會。人工智慧平台可在數分鐘內處理膠囊採集的數千張影像，顯著減輕醫生閱片負擔，同時提高診斷準確率。此外，將智慧膠囊整合到遠端患者監護系統中，可在臨床環境之外持續收集健康數據，從而支援慢性病管理和藥物依從性監測。隨著遠端醫療基礎設施在全球範圍內的擴展，智慧膠囊有望成為邁向數位化胃腸病學和個人化醫療的基石。

嚴格的監管流程和對資料隱私的擔憂

智慧藥丸必須應對複雜且不斷變化的法律規範，因為美國食品藥物管理局 (FDA)、歐盟委員會 (CE) 和其他國家監管機構對新型口服醫療設備製定的標準因地區而異。核准流程耗時耗力，延緩了創新產品的市場進入。除了監管障礙外，透過無線連接傳輸和儲存敏感的患者生理數據也引發了嚴重的隱私和網路安全問題。未授權存取個人健康資料或雲端儲存平台上的資料外洩不僅會損害患者的信任，還會為製造商和醫療保健機構帶來巨大的法律和聲譽風險。

新型冠狀病毒（COVID-19）的影響

新冠疫情一度阻礙了智慧藥丸市場的成長，因為部分診斷程序被推遲，醫院資源也被調配用於應對疫情。生產供應鏈出現延誤，新型膠囊內視鏡產品的臨床試驗週期也延長。然而，疫情同時也加速了人們對遠距離診斷工具和非接觸式病患監測解決方案的興趣。疫情過後，隨著醫療系統恢復運作並重新注重減少面對面就診，包括智慧藥丸在內的非侵入性診斷需求強勁復甦，進一步鞏固了其在現代醫療服務中的戰略重要性。

在預測期內，膠囊內視鏡細分市場預計將佔據最大的市場佔有率。

預計在預測期內，膠囊內視鏡細分市場將佔據最大的市場佔有率，這主要得益於口服型膠囊內視鏡在診斷不明原因的消化道出血、克隆氏症和小腸異常等方面的臨床應用日益廣泛。膠囊內視鏡已成為胃腸病學家首選的診斷方法，因為它提供了一種非侵入性、門診病人即可完成的替代傳統內視鏡檢查的方式。影像解析度、電池續航力和資料傳輸能力的不斷提升，進一步鞏固了其作為智慧膠囊生態系統基礎產品類型的地位。

在預測期內，「智慧藥物輸送藥丸」細分市場預計將呈現最高的複合年成長率。

在預測期內，智慧藥丸領域預計將呈現最高的成長率，這主要得益於標靶和緩釋藥物遞送機制的進步。這些膠囊能夠精準地將藥物治療性介入到胃腸道的特定部位，最大限度地提高局部藥物濃度，同時最大限度地減少全身副作用。口服生物製劑遞送的投資增加以及發炎性腸道病患病率的上升正在推動市場需求。此外，製藥公司正在積極開發整合智慧藥丸的製劑，以提高患者的用藥依從性和治療效果，這使得該領域成為精準醫療的關鍵成長點。

市佔率最大的地區

在預測期內，北美地區預計將佔據最大的市場佔有率，這主要得益於診斷程序的廣泛保險覆蓋以及膠囊內視鏡領域領先製造商和研究機構的聚集。北美人群中消化器官系統和發炎性腸道疾病的高發生率也支撐了持續的臨床需求。此外，美國食品藥物管理局（FDA）嚴格的監管流程以及胃腸病學家對該技術的早期應用，預計將確保這項創新智慧膠囊平台在美國和加拿大市場迅速滲透。

複合年成長率最高的地區

在預測期內，亞太地區預計將呈現最高的複合年成長率。這主要歸功於中國、印度、日本和韓國醫療基礎設施的快速擴張，以及胃腸道疾病患者數量持續成長，從而推動了市場需求。政府主導的醫療現代化舉措和人均醫療費用支出的增加，使得更多人能夠獲得先進的診斷技術。此外，新加坡和泰國等國建立的在地化生產體系，以及醫療旅遊的蓬勃發展，也進一步加速了智慧藥丸解決方案在該地區的應用。

免費客製化服務

所有購買此報告的客戶均可享受以下免費自訂選項之一。

  • 企業概況
    • 對其他市場參與企業（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 透過產品系列、地域覆蓋和策略聯盟對標領先企業。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 成長機會和重點投資領域
  • 工業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球智慧藥丸市場：依產品類型分類

  • 膠囊內視鏡
    • 小腸膠囊內視鏡檢查
    • 結腸膠囊內視鏡檢查
    • 食道膠囊內視鏡
  • 用於藥物輸送的智慧藥丸
    • 緩釋膠囊
    • 標靶藥物輸送膠囊
    • 無線藥物輸送系統
  • 用於病患監測的智慧藥丸
    • 口服型感測器
    • 用於藥物依從性監測的智慧藥丸
    • 用於生命徵象監測的智慧藥丸

第6章 全球智慧藥丸市場：依技術分類

  • 成像技術
  • 感測器技術
  • 通訊科技
  • 人工智慧與數據分析的融合

第7章：全球智慧藥丸市場：以標靶分類

  • 食道
  • 胃
  • 小腸
  • 冒號

第8章：全球智慧藥丸市場：依通路分類

  • 直銷
  • 分銷商銷售額
  • 線上銷售
  • 零售藥房

第9章：全球智慧藥丸市場：按應用分類

  • 胃腸道疾病
  • 神經病變
  • 藥物傳輸應用
  • 病患監測
  • 其他

第10章 全球智慧藥丸市場：依最終用戶分類

  • 醫院
  • 診斷中心
  • 專科診所
  • 門診手術中心
  • 研究機構
  • 居家醫療

第11章 全球智慧藥丸市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 其他
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲地區

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章：產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟、合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Medtronic plc
  • Olympus Corporation
  • CapsoVision Inc.
  • Check-Cap Ltd.
  • IntroMedic Co., Ltd.
  • JINSHAN Science & Technology Group Co., Ltd.
  • RF Co., Ltd.
  • Boston Scientific Corporation
  • Koninklijke Philips NV
  • FUJIFILM Holdings Corporation
  • PENTAX Medical
  • Proteus Digital Health
  • Otsuka Pharmaceutical Co., Ltd.
  • etectRx
  • BodyCap
Product Code: SMRC36780

According to Stratistics MRC, the Global Smart Pills Market is accounted for $4.2 billion in 2026 and is expected to reach $9.8 billion by 2034, growing at a CAGR of 11.2% during the forecast period. Smart Pills, also known as ingestible electronic capsules, are advanced biomedical devices embedded with miniaturized sensors, cameras, and wireless transmitters that travel through the gastrointestinal tract to capture real-time physiological and anatomical data. These devices facilitate non-invasive diagnosis of GI disorders, controlled drug delivery, and continuous patient monitoring. By transmitting data to external receivers or cloud platforms, smart pills enable clinicians to make timely and accurate decisions, improving diagnostic precision while reducing the need for traditional invasive endoscopic procedures and hospital visits.

Market Dynamics:

Driver:

Rising prevalence of gastrointestinal disorders and demand for non-invasive diagnostics

The global burden of gastrointestinal disorders, including Crohn's disease, colorectal cancer, and irritable bowel syndrome, is escalating rapidly, fueling demand for non-invasive diagnostic tools. Smart pills provide a patient-friendly alternative to conventional endoscopy by capturing high-resolution images throughout the GI tract without sedation or procedural discomfort. As healthcare systems prioritize early detection and patient-centric care models, the adoption of capsule endoscopy is accelerating. Additionally, growing awareness among physicians about the diagnostic superiority of smart pills in detecting obscure GI bleeding and small bowel lesions is further propelling market expansion.

Restraint:

High cost of smart pill devices and limited reimbursement coverage

Despite their clinical advantages, smart pills remain financially prohibitive for a significant portion of the global patient population. The devices involve complex manufacturing processes with precision micro-components, translating into elevated unit costs. In many healthcare markets, particularly across developing economies, reimbursement frameworks for capsule endoscopy procedures remain undefined or insufficiently broad, placing the financial burden on patients. Additionally, ancillary costs associated with data management systems and reader equipment further constrain adoption among smaller clinical settings. This economic barrier continues to limit market penetration beyond high-income and well-insured patient groups.

Opportunity:

Integration of AI-driven analytics and remote monitoring capabilities

The convergence of artificial intelligence with smart pill technology is creating transformative opportunities for automated lesion detection, real-time anomaly flagging, and predictive diagnostics. AI-powered platforms can process thousands of capsule-captured images within minutes, significantly reducing physician review burden while improving diagnostic accuracy. Furthermore, the integration of smart pills into remote patient monitoring ecosystems enables continuous health data collection outside clinical settings, supporting chronic disease management and medication adherence monitoring. As telehealth infrastructure expands globally, smart pills are positioned to become a cornerstone of digital gastroenterology and personalized treatment pathways.

Threat:

Stringent regulatory pathways and data privacy concerns

Smart pills must navigate complex and evolving regulatory frameworks across different geographies, with varying standards set by the FDA, CE, and other national authorities for novel ingestible medical devices. The approval process is time-consuming and resource-intensive, delaying market entry for innovative products. Beyond regulatory hurdles, the transmission and storage of sensitive patient physiological data via wireless connectivity raises significant data privacy and cybersecurity concerns. Unauthorized access to personal health data or breaches in cloud storage platforms can undermine patient trust and expose manufacturers and healthcare providers to substantial legal and reputational risks.

Covid-19 Impact:

The COVID-19 pandemic temporarily disrupted smart pill market growth as elective diagnostic procedures were postponed and hospital resources were redirected toward pandemic response. Manufacturing supply chains experienced delays, and clinical trial timelines for new capsule endoscopy products were extended. However, the pandemic concurrently accelerated interest in remote diagnostic tools and contactless patient monitoring solutions. As healthcare systems resumed operations post-pandemic with renewed emphasis on reducing in-person hospital visits, demand for non-invasive diagnostics including smart pills witnessed a strong rebound, reinforcing their strategic importance in modern healthcare delivery.

The Capsule Endoscopy segment is expected to be the largest during the forecast period

The Capsule Endoscopy segment is expected to account for the largest market share during the forecast period, driven by the widespread clinical adoption of ingestible camera capsules for diagnosing obscure gastrointestinal bleeding, Crohn's disease, and small bowel abnormalities. Capsule endoscopy offers a non-invasive, outpatient-friendly alternative to traditional endoscopic procedures, making it the preferred diagnostic modality among gastroenterologists. The continuous refinement of imaging resolution, battery life, and data transmission capabilities has further cemented its position as the foundational product category within the smart pills ecosystem.

The Drug Delivery Smart Pills segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the xx segment is predicted to witness the highest growth rate, propelled by advancements in targeted and controlled-release drug delivery mechanisms. These capsules enable precise therapeutic intervention at specific GI locations, minimizing systemic side effects while maximizing local drug concentrations. Growing investments in oral biologic delivery and the rising prevalence of inflammatory bowel diseases are catalyzing demand. Furthermore, pharmaceutical companies are actively developing smart pill-integrated drug formulations to enhance medication adherence and treatment outcomes, making this segment a key growth frontier in precision medicine.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to widespread insurance coverage for diagnostic procedures, and the presence of leading capsule endoscopy manufacturers and research institutions. The high prevalence of gastrointestinal cancers and inflammatory bowel diseases among the North American population sustains consistent clinical demand. Moreover, robust FDA regulatory pathways and early technology adoption among gastroenterologists ensure that innovative smart pill platforms achieve rapid market penetration across the United States and Canada.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapidly expanding healthcare infrastructure across China, India, Japan, and South Korea, combined with a large and growing patient population suffering from GI disorders, is fueling demand. Government-led healthcare modernization initiatives and increasing per capita healthcare expenditure are enabling wider access to advanced diagnostic technologies. Additionally, the establishment of local manufacturing capabilities and growing medical tourism in countries such as Singapore and Thailand are further accelerating the regional uptake of smart pill solutions.

Key players in the market

Some of the key players in Global Smart Pills Market include Medtronic plc, Olympus Corporation, CapsoVision Inc., Check-Cap Ltd., IntroMedic Co., Ltd., JINSHAN Science & Technology Group Co., Ltd., RF Co., Ltd., Boston Scientific Corporation, Koninklijke Philips N.V., FUJIFILM Holdings Corporation, PENTAX Medical, Proteus Digital Health, Otsuka Pharmaceutical Co., Ltd., etectRx, and BodyCap.

Key Developments:

In January 2026, Medtronic plc announced the commercial launch of its next-generation PillCam CROHN'S capsule system featuring enhanced imaging resolution and extended battery life, enabling comprehensive small bowel assessment. The upgraded platform incorporates AI-assisted image analysis to automatically flag suspicious lesions, reducing physician review time and improving diagnostic confidence for Crohn's disease monitoring.

In March 2026, Otsuka Pharmaceutical and Proteus Digital Health announced a strategic collaboration to expand the clinical use of the Abilify MyCite digital pill system into new therapeutic areas beyond psychiatric care. The partnership focuses on developing ingestible sensor-embedded formulations for oncology and cardiology applications, leveraging real-time medication adherence data to optimize treatment protocols and patient outcomes.

Product Types Covered:

  • Capsule Endoscopy
  • Drug Delivery Smart Pills
  • Patient Monitoring Smart Pills

Technologies Covered:

  • Imaging Technology
  • Sensor Technology
  • Communication Technology
  • AI & Data Analytics Integration

Target Areas Covered:

  • Esophagus
  • Stomach
  • Small Intestine
  • Large Intestine

Distribution Channels Covered:

  • Direct Sales
  • Distributor Sales
  • Online Sales
  • Retail Pharmacies

Applications Covered:

  • Gastrointestinal Disorders
  • Neurological Disorders
  • Drug Delivery Applications
  • Patient Monitoring
  • Other Applications

End Users Covered:

  • Hospitals
  • Diagnostic Centers
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Research Institutes
  • Home Care Settings

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Smart Pills Market, By Product Type

  • 5.1 Capsule Endoscopy
    • 5.1.1 Small Bowel Capsule Endoscopy
    • 5.1.2 Colon Capsule Endoscopy
    • 5.1.3 Esophageal Capsule Endoscopy
  • 5.2 Drug Delivery Smart Pills
    • 5.2.1 Controlled Release Capsules
    • 5.2.2 Targeted Drug Delivery Capsules
    • 5.2.3 Wireless Drug Delivery Systems
  • 5.3 Patient Monitoring Smart Pills
    • 5.3.1 Ingestible Sensors
    • 5.3.2 Medication Adherence Monitoring Pills
    • 5.3.3 Vital Sign Monitoring Pills

6 Global Smart Pills Market, By Technology

  • 6.1 Imaging Technology
  • 6.2 Sensor Technology
  • 6.3 Communication Technology
  • 6.4 AI & Data Analytics Integration

7 Global Smart Pills Market, By Target Area

  • 7.1 Esophagus
  • 7.2 Stomach
  • 7.3 Small Intestine
  • 7.4 Large Intestine

8 Global Smart Pills Market, By Distribution Channel

  • 8.1 Direct Sales
  • 8.2 Distributor Sales
  • 8.3 Online Sales
  • 8.4 Retail Pharmacies

9 Global Smart Pills Market, By Application

  • 9.1 Gastrointestinal Disorders
  • 9.2 Neurological Disorders
  • 9.3 Drug Delivery Applications
  • 9.4 Patient Monitoring
  • 9.5 Other Applications

10 Global Smart Pills Market, By End User

  • 10.1 Hospitals
  • 10.2 Diagnostic Centers
  • 10.3 Specialty Clinics
  • 10.4 Ambulatory Surgical Centers
  • 10.5 Research Institutes
  • 10.6 Home Care Settings

11 Global Smart Pills Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Medtronic plc
  • 14.2 Olympus Corporation
  • 14.3 CapsoVision Inc.
  • 14.4 Check-Cap Ltd.
  • 14.5 IntroMedic Co., Ltd.
  • 14.6 JINSHAN Science & Technology Group Co., Ltd.
  • 14.7 RF Co., Ltd.
  • 14.8 Boston Scientific Corporation
  • 14.9 Koninklijke Philips N.V.
  • 14.10 FUJIFILM Holdings Corporation
  • 14.11 PENTAX Medical
  • 14.12 Proteus Digital Health
  • 14.13 Otsuka Pharmaceutical Co., Ltd.
  • 14.14 etectRx
  • 14.15 BodyCap

List of Tables

  • Table 1 Global Smart Pills Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Smart Pills Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Smart Pills Market Outlook, By Capsule Endoscopy (2023-2034) ($MN)
  • Table 4 Global Smart Pills Market Outlook, By Small Bowel Capsule Endoscopy (2023-2034) ($MN)
  • Table 5 Global Smart Pills Market Outlook, By Colon Capsule Endoscopy (2023-2034) ($MN)
  • Table 6 Global Smart Pills Market Outlook, By Esophageal Capsule Endoscopy (2023-2034) ($MN)
  • Table 7 Global Smart Pills Market Outlook, By Drug Delivery Smart Pills (2023-2034) ($MN)
  • Table 8 Global Smart Pills Market Outlook, By Controlled Release Capsules (2023-2034) ($MN)
  • Table 9 Global Smart Pills Market Outlook, By Targeted Drug Delivery Capsules (2023-2034) ($MN)
  • Table 10 Global Smart Pills Market Outlook, By Wireless Drug Delivery Systems (2023-2034) ($MN)
  • Table 11 Global Smart Pills Market Outlook, By Patient Monitoring Smart Pills (2023-2034) ($MN)
  • Table 12 Global Smart Pills Market Outlook, By Ingestible Sensors (2023-2034) ($MN)
  • Table 13 Global Smart Pills Market Outlook, By Medication Adherence Monitoring Pills (2023-2034) ($MN)
  • Table 14 Global Smart Pills Market Outlook, By Vital Sign Monitoring Pills (2023-2034) ($MN)
  • Table 15 Global Smart Pills Market Outlook, By Technology (2023-2034) ($MN)
  • Table 16 Global Smart Pills Market Outlook, By Imaging Technology (2023-2034) ($MN)
  • Table 17 Global Smart Pills Market Outlook, By Sensor Technology (2023-2034) ($MN)
  • Table 18 Global Smart Pills Market Outlook, By Communication Technology (2023-2034) ($MN)
  • Table 19 Global Smart Pills Market Outlook, By AI & Data Analytics Integration (2023-2034) ($MN)
  • Table 20 Global Smart Pills Market Outlook, By Target Area (2023-2034) ($MN)
  • Table 21 Global Smart Pills Market Outlook, By Esophagus (2023-2034) ($MN)
  • Table 22 Global Smart Pills Market Outlook, By Stomach (2023-2034) ($MN)
  • Table 23 Global Smart Pills Market Outlook, By Small Intestine (2023-2034) ($MN)
  • Table 24 Global Smart Pills Market Outlook, By Large Intestine (2023-2034) ($MN)
  • Table 25 Global Smart Pills Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 26 Global Smart Pills Market Outlook, By Direct Sales (2023-2034) ($MN)
  • Table 27 Global Smart Pills Market Outlook, By Distributor Sales (2023-2034) ($MN)
  • Table 28 Global Smart Pills Market Outlook, By Online Sales (2023-2034) ($MN)
  • Table 29 Global Smart Pills Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 30 Global Smart Pills Market Outlook, By Application (2023-2034) ($MN)
  • Table 31 Global Smart Pills Market Outlook, By Gastrointestinal Disorders (2023-2034) ($MN)
  • Table 32 Global Smart Pills Market Outlook, By Neurological Disorders (2023-2034) ($MN)
  • Table 33 Global Smart Pills Market Outlook, By Drug Delivery Applications (2023-2034) ($MN)
  • Table 34 Global Smart Pills Market Outlook, By Patient Monitoring (2023-2034) ($MN)
  • Table 35 Global Smart Pills Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 36 Global Smart Pills Market Outlook, By End User (2023-2034) ($MN)
  • Table 37 Global Smart Pills Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 38 Global Smart Pills Market Outlook, By Diagnostic Centers (2023-2034) ($MN)
  • Table 39 Global Smart Pills Market Outlook, By Specialty Clinics (2023-2034) ($MN)
  • Table 40 Global Smart Pills Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 41 Global Smart Pills Market Outlook, By Research Institutes (2023-2034) ($MN)
  • Table 42 Global Smart Pills Market Outlook, By Home Care Settings (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.